Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule
Authors:
- Rajko MedenicaRMRajko Medenica
- Nelson SlackNSNelson Slack
- 1 January 1985
- journal article
- research article
- Published by SAGE Publications in Cancer Drug Delivery
- Vol. 2 (1) , 53-76
Abstract
The efficacy of Human 6 IFN (HLIFN) given in a pulse fashion was determined in a phase II study. Ninety-one cancer patients were evaluated (9 myeloma, 12 breast, 14 prostate, 9 melanoma, 4 renal, 6 astrocytoma, 7 ovarian, 9 large bowel, 7 gastric, 14 head and neck). They all had advanced progressive cancer that was resistant to chemotherapy and/or radiotherapy. Patients were treated by intramuscular injection of 6 × 102 I.U./m2 for three consecutive days every four weeks. 84 patients were evaluable. Complete clinical response was obtained in 23 patients (4 myeloma, 2 breast, 5 prostate, 1 melanoma, 1 renal, 2 astrocytoma, 2 ovarian, 2 large bowel, 1 gastric, 3 head and neck). Partial responses were observed in 35 patients (3 myeloma, 7 breast, 6 prostate, 4 melanoma, 1 renal, 2 astrocytoma, 3 ovarian, 4 head and neck). Objective responses were related (P<0.01) to serum IFN level, with complete and partial responses (P<0.01) more commonly seen in those patients whose serum IFN levels at two hours were in the range of 1000 to 1650 I.U./ml. Side effects resulting from pulse IFN were acceptable for this group of patients and consisted of fever, transient chills, malaise and asthenia, and transient thrombocytopenia and leukocytopenia. The extent of fever was directly related (P<0.01) to response, and was most elevated in patients who achieved objective responses. IFN administered in a pulse fashion appears to be more effective than daily IFN and merits further evaluation.Keywords
This publication has 14 references indexed in Scilit:
- Leukocyte-Derived Interferon (Alpha) in Human Breast CarcinomaAnnals of Internal Medicine, 1982
- Effect of interferon in therapy of skin and head and neck tumorsJournal of Cancer Research and Clinical Oncology, 1981
- [4] Production of interferon in human leukocytes from normal donors with the use of Sendai virus1981
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Interferon: An anti-cancer agent?Cancer Treatment Reviews, 1979
- A Sensitive Interferon Assay for Many Species of Cells: Encephalomyocarditis Virus Hemagglutinin Yield ReductionExperimental Biology and Medicine, 1977
- Antiviral and Non-antiviral Activity of Highly Purified InterferonNature New Biology, 1973
- Mechanism of the Antitumour Effect of Interferon in MiceNature, 1972
- Enhancement by Interferon of the Specific Cytotoxicity of Sensitized LymphocytesProceedings of the National Academy of Sciences, 1972
- Virus interference. I. The interferonProceedings of the Royal Society of London. B. Biological Sciences, 1957